Authors


Jason Handza, DO

Latest:

Electronic health records: Moving beyond 'just a requirement'

Cutting-edge solutions are emerging in healthcare that streamline data capture through a user-friendly interface, leading to an increase in quality and accuracy of data collection while freeing physicians to spend more time with patients.


Denise Visco, MD, MBA

Latest:

Takeaway points from patient case #2

Denise Visco, MD, MBA, discusses takeaway points from patient case #2 for post-operative inflammation management for routine cataract surgery.



George N. Magrath, MD, MBA, MS

Latest:

The future of decentralized clinical trials in ophthalmology

Research can drive opportunities for patients with rare diseases


Blake K. Williamson, MD, MPH, MS

Latest:

Patient Case #2 Initial Impressions

Blake K Williamson MD, MPH, MS, discussed initial impressions of a female patient with high myopia and astigmatism who is an ideal candidate for phakic IOL implant.


Manuele Michelessi, MD

Latest:

Pivotal study data drive glaucoma patient treatment decisions

Two trials examine factors affecting the risk of disease.


Ngoc Pham, MBA

Latest:

Providing comprehensive eye care for diabetic patients in southern Vietnam

Community-based eye care is one of Orbis’s top priorities in the country.



Michael J. Shumski, MD, MSE

Latest:

Is office-based surgery a harbinger of things to come for ophthalmology?

One practice’s experience with office-based surgery validates peer-reviewed study.


Greg Pierce

Latest:

Creating a positive patient financial journey for refractive error procedures

Clear communication, transparent priceing, options are key to positive experience


Ramin Tadayoni, MD, PhD

Latest:

Quest continues for topical treatments for posterior segment

Novel treatments are now shifting paradigm in care of retinal diseases.


Bela Parekh

Latest:

Balancing Motherhood and Medicine: Navigating Maternity in Ophthalmology

Balancing motherhood & ophthalmology: Prioritize family planning, set boundaries, integrate work & personal life. Insights from ophthalmologist-moms.


Aleksandra Rachitskaya, MD

Latest:

Rare Disease Day: What it means for the future of inherited retinal diseases

Aleksandra Rachitskaya, MD, discusses how the treatment landscape for inherited retinal diseases has changed and her hope for the future.


Marc D. de Smet, MD, PhD

Latest:

Managing neovascular retinal disease in COVID-19 era requires careful approach

Minimizing clinic visits, maximizing use of imaging modalities are key.


Shlomo Melamed, MD

Latest:

Lessons from the Togo Glaucoma Project

SLT shows promise as treatment for millions of Africans with glaucoma.



Fotis Topouzis, MD, PhD

Latest:

Unraveling the genetics of glaucoma

Details enhance knowledge of biological pathways that contribute to disease pathogenesis.


Michael Savetsky, MD

Latest:

Real-world outcomes validate intraocular drug delivery method

Ophthalmologists seek methods to control postoperative inflammation.


Chirag Jhaveri, MD

Latest:

Clinical Implications of Port Delivery System in Retinal Diseases

Closing out his discussion on the port delivery system in retinal diseases, Chirag Jhaveri, MD, considers how this approach has impacted the treatment landscape.


SPONSORED BY BAUSCH + LOMB

Latest:

A Cataract Case Study with Dr. Rahul Pandit

Using an NSAID to Manage Inflammation and Pain After Cataract Surgery


John H. Merey, MD

Latest:

Ophthalmologist Holocaust survivor shares his story

In observance of International Holocaust Remembrance Day this January 27, John H. Merey, MD, may be the only Holocaust survivor still in the practice of ophthalmology.


Ashlie Leal

Latest:

Virtual reality brings care to at-need areas

Technology offers accessibility, scalability to countries where care is needed the most.


Haoxing Douglas Jin, MD

Latest:

Ocular manifestations of mycoplasma-induced rash and mucositis

Aggressive lubrication combined with topical steroids, antibiotics boosts chances of recovery.


Sara Giammaria, MD

Latest:

Pivotal study data drive glaucoma patient treatment decisions

Two trials examine factors affecting the risk of disease.


Ferdinand K. Hui, MD

Latest:

Clearing hurdles to large scale telemedicine adoption

During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of the eye


Vanita Berry, PhD

Latest:

Focus on molecular mechanisms underlying cataract development

Several hundred genes are associated with congenital forms.


Boris Malyugin, MD, PhD

Latest:

Cataract surgery pearls for cases with poor mydriasis, zonules

Factors that lead to complications must be managed for best outcomes.


Dimitrios Giannoulis, MD

Latest:

Unraveling the genetics of glaucoma

Details enhance knowledge of biological pathways that contribute to disease pathogenesis.


Beeran Meghpara, MD

Latest:

Cyropreserved amniotic membrane option for management of DED, NK

Treatment requires a systematic, multifaceted approach to improve outcomes.


Austin F. Cheng, Esq

Latest:

Payment points: The ASC perspective

Transparent pricing in elective surgeries is crucial.

© 2024 MJH Life Sciences

All rights reserved.